SKI
protein-codingSKI proto-oncogene, the group of SKI transcriptional corepressors
Gene summary
This gene encodes the nuclear protooncogene protein homolog of avian sarcoma viral (v-ski) oncogene. It functions as a repressor of TGF-beta signaling, and may play a role in neural tube development and muscle differentiation. [provided by RefSeq, Oct 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~82.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008426
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008426
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0008426
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008426
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0008426
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0008426
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008426
Submitter: ClinGen
SKI was first reported in relation to Shprintzen-Goldberg syndrome (SGS) as early as 2012 (Doyle et al., Carmignac et al.; PMIDs: 23023332, 23103230). Clinical phenotypes of SGS include craniosynostosis and craniofacial features, motor and cognitive delays, mild-moderate intellectual disability, hypotonia, musculoskeletal anomalies, and cardiovascular problems such as aortic aneurysm. Variants in SKI have been identified in at least 40 probands with SGS (GeneReviews, Greally, 2020). Seven variants (missense and in-frame indel) reported in 13 probands in 4 publications (PMID: 23023332, 23103230, 24357594, 4736733) are included in this curation. Additionally, there is evidence that variants affecting amino acid position p.Thr180 may lead to phenotypes including thoracic aortic aneurysm and a marfanoid body habitus without intellectual disability, a feature which is often characteristic of SGS (PMID: 31980905). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is proposed to be dominant-negative (PMID: 23023332). Variants in SKI associated with SGS are concentrated in exon 1, a mutational hotspot, where variants exert a stabilizing effect on SKI protein function, attenuating the TGF-β signaling pathway (PMID: 33416497). This gene-disease association is also supported by experimental evidence including expression studies, animal models, and in vitro functional assays (PMID: 10906458, 23023332). In summary, SKI is definitively associated with Shprintzen-Goldberg syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This curation was approved by the ClinGen Craniofacial Malformations Gene Curation Expert Panel on 10/29/20 (SOP Version 8). The evidence summary was updated by the Heritable Thoracic Aortic Aneurysm and Dissection subgroup of the Hereditary Cardiovascular Disease Gene Curation Expert Panel on 7/23/2024.
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Musculoskeletal; Neurologic
Intervention: Cardiovascular
Rationale: Individuals have been described with a number of cardiovascular anomalies, including aortic root dilatation, and spontaneous rupture of arterial aneurysms, and surveillance (eg, including echocardiogram) may allow early management, decreasing morbidity and mortality
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SKI variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003036.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 534 | 4 | 542 | ||
| missense | 13 | 17 | 604 | 111 | 2 | 747 |
| nonsense | 11 | 11 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 2 | 21 | 24 | ||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 5 | |||
| Total | 14 | 20 | 645 | 645 | 6 | 1330 |
Highest pathogenic variant AF is 0.0000031012444
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003027.1 | 7 | MANE Select | |
| Ensembl | ENSP00000367797.4 | 7 | MANE Select | |
| Ensembl | ENSP00000521247.1 | 7 | Standard | |
| Ensembl | ENSP00000521247.1 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| skia | Danio rerio | Structure: bulbus arteriosus Quality: amorphous abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TGF-Ncore
- Olfactory bulb development and olfactory learning
- TGF-beta Signaling Pathway
- TGF-beta Receptor Signaling
- Signal Transduction
Biological Process
- negative regulation of transcription by RNA polymerase II
- neural tube closure
- lens morphogenesis in camera-type eye
- transcription, DNA-templated
- transforming growth factor beta receptor signaling pathway
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- transcription corepressor activity
- protein binding
- zinc ion binding
- protein kinase binding
Cellular Component
- nucleus
- nucleoplasm
- transcription factor complex
- cytoplasm
- centrosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378536
- Coding exons
- 7
- Length
- 81425
- Individuals with no LoFs
- 125412
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 3
- Defined
- 125415
- p
- 0.0000120
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.51 | 349 | 438 | 0.796 | 0.0000288 | 4563 |
| Missense (PolyPhen) | 93 | 185.76 | 0.50065 | 1946 | ||
| Synonymous | -4.87 | 300 | 210 | 1.43 | 0.0000147 | 1536 |
| Loss of Function | 4.40 | 1 | 24.5 | 0.0409 | 0.00000123 | 293 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00010 | 0.00010 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in terminal differentiation of skeletal muscle cells but not in the determination of cells to the myogenic lineage. Functions as a repressor of TGF-beta signaling. {ECO:0000269|PubMed:19049980}.;
- Disease
- DISEASE: Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212]: A very rare syndrome characterized by a marfanoid habitus, craniosynostosis, characteristic dysmorphic facial features, skeletal and cardiovascular abnormalities, mental retardation, developmental delay and learning disabilities. {ECO:0000269|PubMed:23023332, ECO:0000269|PubMed:23103230, ECO:0000269|PubMed:24357594, ECO:0000269|PubMed:24736733}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.152
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 1.00
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |